This is an HTML version of an attachment to the Freedom of Information request 'Meetings with the pharmaceutical industry since March 1st 2020'.


From:
) on behalf of 
 (SANTE)
To:
Cc:
 (SANTE)
Bcc:
 (SANTE); 
 (SANTE); 
 (SANTE)
Subject:
RE: Pharmaceutical Roadmap consultation - Question
Date:
jeudi 11 juin 2020 14:19:00
Attachments:
image001.png
Dear 
 
Thank you for taking the time to participate in the feedback mechanism on the pharmaceutical
strategy roadmap. Indeed the text reply is limited in characters but you should be able to attach
a position paper as well.
 
I hope this helps.
 
Kind regards,
 
ec
European Commission
Health and Food Safety Directorate General (SANTE)
B-1049 Brussels, Belgium
 
From: 
 
Sent: Thursday, June 11, 2020 1:00 PM
To: 
Subject: Pharmaceutical Roadmap consultation - Question
 
Dear 
 
I hope this message finds you well and healthy.
 
I'm reaching out for a quick question regarding the public consultation just started in relation
with the Pharmaceutical Strategy Roadmap. The online format of the response seems to
indicate that any contribution is limited to 4000 characters. Given that this is rather short, I
wanted to check with you whether it is possible to provide a slightly longer contribution in the
form of an attachment.
 
Sorry to bother you with such mundane question, but I would like to make sure that our
contribution follows the expected format.
 
Many thanks in advance and wishing you all the best,
 
 

MSD - 10/12 Cours Michelet 92800 Puteaux - France
Transarency register n°: 09824113589-92
DO YOU KNOW OUR POLICY PASSPORT?
 
Today's MSD is a global healthcare leader working to help the world be well. MSD
is a tradename of Merck & Co., Inc., Kenilworth, N.J., U.S.A. Through our
prescription medicines, vaccines, biologic therapies, and consumer care and animal
health products, we work with customers and operate in more than 140 countries to
deliver innovative health solutions. We also demonstrate our commitment to
increasing access to healthcare through far-reaching policies, programs and
partnerships. For more information, visit www.msd.com